Aligos Therapeutics Inc logo

Aligos Therapeutics Inc (ALGS)

$0.71

Aligos Therapeutics Inc (ALGS) Share Price Forecast
Currently 9 wall-street analysts regularly analyze the financials of Aligos Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 9 analysts offering 12-month price forecasts for Aligos Therapeutics Inc (ALGS) have a share price target of $4. This median of share price forecast represents a 463.22% upside from the latest price of $0.71 as on 28.09.23.

Aligos Therapeutics Inc (ALGS) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Aligos Therapeutics Inc (ALGS) share price will touch around $4 in next 12-months.
Aligos Therapeutics Inc (ALGS) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Aligos Therapeutics Inc's share price and its median forecast price. As on 28.09.23, the difference is -78.25%

Aligos Therapeutics Inc (ALGS): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Aligos Therapeutics Inc (ALGS) Share Price : Analyst Recommendation
Based on 9 analysts tracking and researching Aligos Therapeutics Inc (ALGS) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
4
4
4
Outperform
3
3
3
Hold
2
2
2
Underperform
0
0
0
Sell
0
0
0
Aligos Therapeutics Inc (ALGS) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Aligos Therapeutics Inc (ALGS) is $4, offered by 9 analysts offering 12-month price forecasts.

Aligos Therapeutics Inc (ALGS) has a maximum of 4.63 upside potential, based on 9 analysts offering 12-month price forecasts.

Based on 9 analysts tracking and researching Aligos Therapeutics Inc (ALGS), 77.78% have a buy recommendation. Remaining 22.22% have either sell or hold recommendations.

The latest share price of Aligos Therapeutics Inc (ALGS) is $0.71 as of 28/09/2023.

7 of total 9 analysts offering stock ratings for Aligos Therapeutics Inc ALGS have recommended buy rating.